Chad Bello
Financieel Directeur/CFO bij Prolexys Pharmaceuticals, Inc.
Profiel
Chad Bello is Finance Director for Prolexys Pharmaceuticals, Inc. Prior to joining Prolexys in January, 2002 he was a Senior Accountant for Porter & Porter.
He received a Bachelor's degree in Accounting from the University of Utah and an MBA from Westminster College.
Actieve functies van Chad Bello
Bedrijven | Functie | Begin |
---|---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Financieel Directeur/CFO | 01-01-2002 |
Eerdere bekende functies van Chad Bello
Bedrijven | Functie | Einde |
---|---|---|
Porter & Associates
Porter & Associates Publishing: Books/MagazinesConsumer Services Part of Ascend Learning LLC, Porter & Associates is a publisher of pocket guides for healthcare professionals and institutions. Porter & Associates was acquired by Jones & Bartlett Publishers, Inc. on April 19, 2006. | Comptroller/Controller/Auditor | - |
Opleiding van Chad Bello
University of Utah | Undergraduate Degree |
Westminster College (Utah) | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Porter & Associates
Porter & Associates Publishing: Books/MagazinesConsumer Services Part of Ascend Learning LLC, Porter & Associates is a publisher of pocket guides for healthcare professionals and institutions. Porter & Associates was acquired by Jones & Bartlett Publishers, Inc. on April 19, 2006. | Consumer Services |